Rituximab and cyclosporine therapy for accelerated phase Chediak–Higashi syndrome

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pediatric Blood & Cancer

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pbc.23231PMID 21681939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Post‐transplant lymphoproliferative disorder in children: Recent outcomes and response to dual rituximab/low‐dose chemotherapy combination

  2010cited by this paper
• Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.

  2010cited by this paper
• Post‐transplant lymphoproliferative disorders in children: The role of chemotherapy in the era of rituximab

  2010cited by this paper
• Hematopoietic cell transplantation for Chediak–Higashi syndrome

  2007influential reference
• Familial and acquired hemophagocytic lymphohistiocytosis.

  2007cited by this paper
• Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.

  2007cited by this paper
• HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

  2007influential reference
• Familial and acquired hemophagocytic lymphohistiocytosis

  2006influential reference
• Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome.

  2004cited by this paper
• Modern management of children with haemophagocytic lymphohistiocytosis

  2004influential reference
• Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.

  2001cited by this paper
• Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

  2001cited by this paper
• The role of high dose methylprednisolone and splenectomy in the accelerated phase of Chédiak-Higashi syndrome.

  1996influential reference
• Successful treatment of virus‐associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony‐stimulating factor

  1996cited by this paper
• Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases.

  1995influential reference
• Virus‐associated haemophagocytic syndrome: further evidence for a T‐cell mediated disorder

  1994cited by this paper
• Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue.

  1992cited by this paper
• Acyclovir in accelerated phase of Chediak-Higashi syndrome.

  1987influential reference
• The accelerated phase of Chediak‐Higashi syndrome. An expression of the virus‐associated hemophagocytic syndrome?

  1985cited by this paper
• Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.

  1979cited by this paper
• Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.

  1976cited by this paper

• Albinism

  2019cites this paper
• Herpesvirus-assoziierte lymphoproliferative Erkrankungen und maligne Lymphome

  2018cites this paper
• Epstein–Barr virus infection in primary immunodeficiency

  2018cites this paper
• Allogeneic hematopoietic stem cell transplantation for Chediak–Higashi syndrome

  2016influential citation
• The immunology of Epstein-Barr virus-induced disease.

  2015cites this paper
• Practice parameter for the diagnosis and management of primary immunodeficiency.

  2015cites this paper
• Infantile Hemophagocytic Lymphohistiocytosis in a Case of Chediak-Higashi Syndrome Caused by a Mutation in the LYST/CHS1 Gene Presenting With Delayed Umbilical Cord Detachment and Diarrhea

  2015cites this paper
• Primary immunodeficiencies and the control of Epstein–Barr virus infection

  2015cites this paper
• Chediak–Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype

  2014cites this paper
• Towards the targeted management of Chediak-Higashi syndrome

  2014cites this paper
• Chédiak–Higashi syndrome

  2013cites this paper
• Introduction to autoinflammatory syndromes and diseases.

  2013cites this paper
• Molecular Genetics of Chediak–Higashi Syndrome

  2013cites this paper
• Syndromes and Diseases

  2013cites this paper
• Hemophagocyctic lymphohistiocytosis developed in a Japanese boy with Chédiak-Higashi syndrome.

  2013cites this paper
• Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia B

  2012cites this paper